AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2021

Nov 30, 2021

30071_dirs_2021-11-29_b25fd6ee-d633-40ad-b89e-fbd87f89564a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-11-23

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-23	ResMed Common Stock	G	791	—	Disposed	234995	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	17175	Direct

Footnotes

F1: Represents a gift of shares to Fidelity Charitable, a donor advised fund. Mr. Douglas has no beneficial interest, control or dispositive power over the gifted shares.

F2: Includes a transfer of shares between direct and indirect holdings on 11/23/2021.

F3: Includes a transfer of shares between direct and indirect holdings on 11/23/2021.